HK1033426A1 - An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition - Google Patents

An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition

Info

Publication number
HK1033426A1
HK1033426A1 HK01104034A HK01104034A HK1033426A1 HK 1033426 A1 HK1033426 A1 HK 1033426A1 HK 01104034 A HK01104034 A HK 01104034A HK 01104034 A HK01104034 A HK 01104034A HK 1033426 A1 HK1033426 A1 HK 1033426A1
Authority
HK
Hong Kong
Prior art keywords
iron
compound
therapeutical composition
dextran
prophylaxis
Prior art date
Application number
HK01104034A
Other languages
English (en)
Inventor
Hans Berg Andreasen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8093321&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1033426(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of HK1033426A1 publication Critical patent/HK1033426A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK01104034A 1998-03-25 2001-06-13 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition HK1033426A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK199800420A DK172860B1 (da) 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
PCT/DK1999/000160 WO1999048533A1 (en) 1998-03-25 1999-03-24 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition

Publications (1)

Publication Number Publication Date
HK1033426A1 true HK1033426A1 (en) 2001-08-31

Family

ID=8093321

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104034A HK1033426A1 (en) 1998-03-25 2001-06-13 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition

Country Status (28)

Country Link
US (1) US6291440B1 (zh)
EP (1) EP1066056B2 (zh)
JP (1) JP4558198B2 (zh)
KR (1) KR100612071B1 (zh)
CN (1) CN1147322C (zh)
AR (1) AR015738A1 (zh)
AT (1) ATE220560T1 (zh)
AU (1) AU740432B2 (zh)
BR (1) BRPI9908914B8 (zh)
CA (1) CA2322633C (zh)
CZ (1) CZ300823B6 (zh)
DE (1) DE69902154T3 (zh)
DK (2) DK172860B1 (zh)
EA (1) EA003427B1 (zh)
ES (1) ES2180279T5 (zh)
HK (1) HK1033426A1 (zh)
HU (1) HU228483B1 (zh)
ID (1) ID26778A (zh)
NO (1) NO329591B1 (zh)
NZ (1) NZ505983A (zh)
PL (1) PL195582B1 (zh)
PT (1) PT1066056E (zh)
SI (1) SI1066056T2 (zh)
SK (1) SK284499B6 (zh)
TR (1) TR200002733T2 (zh)
UA (1) UA70939C2 (zh)
WO (1) WO1999048533A1 (zh)
ZA (1) ZA200004016B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
DK1169062T3 (da) * 1999-04-09 2010-01-25 Amag Pharmaceuticals Inc Varmestabile overtrukne kolloide jernoxider
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
KR20020003344A (ko) * 2001-12-17 2002-01-12 유형선 철분 보급제 경구 투여 제제 조성물
CN1309741C (zh) * 2002-04-09 2007-04-11 法玛科思莫斯控股有限公司 用于治疗缺铁性贫血的铁糊精化合物
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de) 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
CN101365458B (zh) 2006-01-06 2012-09-05 卢特波尔德药品公司 用于铁给药的方法和组合物
EP1947120A1 (de) * 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
EP1997833A1 (de) * 2007-05-29 2008-12-03 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
CN101585887B (zh) * 2008-05-22 2011-12-14 中国科学院过程工程研究所 应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法
NZ595597A (en) * 2009-03-25 2013-05-31 Pharmacosmos Holding As A stable iron oligosaccharide compound
CN101967205B (zh) * 2010-10-12 2013-04-17 滨州学院 一种β-葡聚糖铁复合物及其制备方法
EP2537866A1 (en) * 2011-06-21 2012-12-26 Serumwerk Bernburg AG Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PL398814A1 (pl) 2012-04-16 2013-10-28 Uniwersytet Jagiellonski Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
ES2743223T3 (es) * 2014-10-27 2020-02-18 Pharmacosmos Holding As Tratamiento o prevención de la anemia en mamíferos no humanos gestantes y crías
BR112020004357A2 (pt) * 2017-09-11 2020-09-08 Pharmacosmos Holding A/S compostos de complexo de ferro para uso terapêutico
CN109646454A (zh) * 2018-12-29 2019-04-19 博瑞生物医药（苏州）股份有限公司 异麦芽糖酐铁1000的制备方法
CN110183548B (zh) * 2019-06-28 2021-05-18 瑞普（天津）生物药业有限公司 一种低分子葡聚糖铁的制备方法及其应用
JP2024529536A (ja) 2021-08-03 2024-08-06 ファーマコスモス ホールディング エー／エス コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK117730A (zh)
USRE24642E (en) 1959-04-28 Therapeutic preparations of iron
US2885393A (en) 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3093545A (en) 1960-08-29 1963-06-11 Armour Pharma Therapeutic iron-dextran preparations
US3234209A (en) * 1963-09-13 1966-02-08 Chemicals Inc Process for making iron hydrogenated dextran
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
GB1200902A (en) 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
CH507993A (de) 1967-07-13 1971-05-31 Kutnowskie Zakl Farma Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran
DK129353B (da) 1968-04-29 1974-09-30 Fisons Pharmaceuticals Ltd Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf.
US3697502A (en) 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
GB1562913A (en) * 1976-06-16 1980-03-19 Fisons Ltd Fractionating fluid mixtures of dextrans
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5102652A (en) 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
RU2093577C1 (ru) * 1993-11-04 1997-10-20 Государственный институт кровезаменителей и медицинских препаратов Способ получения декстрана
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
US5624668A (en) * 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations

Also Published As

Publication number Publication date
CZ20003535A3 (cs) 2001-04-11
ES2180279T3 (es) 2003-02-01
EP1066056B2 (en) 2008-12-10
KR100612071B1 (ko) 2006-08-11
UA70939C2 (uk) 2004-11-15
SK284499B6 (sk) 2005-05-05
CZ300823B6 (cs) 2009-08-19
ATE220560T1 (de) 2002-08-15
DK1066056T3 (da) 2002-10-14
CN1147322C (zh) 2004-04-28
DK42099A (da) 1999-08-16
JP2002507582A (ja) 2002-03-12
TR200002733T2 (tr) 2000-12-21
ES2180279T5 (es) 2009-05-05
EP1066056B1 (en) 2002-07-17
DE69902154T2 (de) 2003-03-06
ZA200004016B (en) 2001-07-25
HU228483B1 (en) 2013-03-28
EA200000981A1 (ru) 2001-02-26
PL343164A1 (en) 2001-07-30
KR20010034641A (ko) 2001-04-25
CA2322633A1 (en) 1999-09-30
AU740432B2 (en) 2001-11-01
JP4558198B2 (ja) 2010-10-06
CN1293577A (zh) 2001-05-02
PT1066056E (pt) 2002-12-31
WO1999048533A1 (en) 1999-09-30
US6291440B1 (en) 2001-09-18
DK1066056T4 (da) 2009-04-14
NO20004151L (no) 2000-08-18
NO20004151D0 (no) 2000-08-18
EA003427B1 (ru) 2003-04-24
EP1066056A1 (en) 2001-01-10
CA2322633C (en) 2009-01-27
PL195582B1 (pl) 2007-10-31
HUP0101189A3 (en) 2003-12-29
ID26778A (id) 2001-02-08
BRPI9908914A (pt) 2000-11-21
DE69902154D1 (de) 2002-08-22
BRPI9908914B1 (pt) 2012-06-12
BRPI9908914B8 (pt) 2021-07-06
SI1066056T2 (sl) 2009-04-30
HUP0101189A2 (hu) 2001-08-28
AU2827399A (en) 1999-10-18
NO329591B1 (no) 2010-11-15
SK14092000A3 (sk) 2001-04-09
DE69902154T3 (de) 2009-07-09
SI1066056T1 (en) 2002-12-31
NZ505983A (en) 2002-11-26
DK172860B1 (da) 1999-08-16
AR015738A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
PL343164A1 (en) An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition
CA2140106A1 (en) Method of treating hyperproliferative vascular disease
CA2195213A1 (en) Use of droloxifene for the treatment of cardiovascular diseases
WO2000074662A3 (en) Arthritis treatment
CA2373794A1 (en) Compositions and uses of et743 for treating cancer
CA2001765A1 (en) Chelants possessing ortho ligating functionality and complexes thereof
MY129173A (en) Novel cyclopentene derivatives useful as antagonists of the motilin receptor
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
HK1037517A1 (en) Use of apomorphine in the treatment of premature ejaculation
WO1999011256A8 (fr) L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme
HK1009717A1 (en) Golden decorative part and process for producing the same
GB9917346D0 (en) Medicament for treating premature ejaculation
ZA946049B (en) Process for treating zinciferous surfaces to improve resistance to both blackening and white rusting
IL143304A0 (en) The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
IL141164A0 (en) 1,2 tricyclic tetrahydroisoquinoline compounds indicated to be useful in the treatment and prophylaxis of epilepsy, migraine and other disorders
ZA955514B (en) Process for the preparation of 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones
HK1004660A1 (en) Composition for treating hyperosteogeny and process for the preparation thereof
EP1176137A4 (en) POWDER IRON COMPLEX OF S, S-ETHYLENEDIAMINE-N, N'-DISUCCINIC ACID AND PROCESS FOR PRODUCING THE SAME
AU1176000A (en) Process for nitriding metal articles and salt bath and composition for use in the process
HU9903046D0 (en) Cpmplex compound useful in treating iron deficiency, pharmaceutical composition containing same, and process for producing same
HU9601450D0 (en) Process for producing pharmaceutical composition for treating neoplasmic syndromas
PL330017A1 (en) Method of obtaining a preparation, in particular in the form of ointment, for treating prophyriate patients
HU9802515D0 (en) Pharmaceutical compositions for treating allergias and process for producing former compositions
HU9801794D0 (en) Easy making unsaturated polyester-based composition for reparatur-set and process for producing same

Legal Events

Date Code Title Description
PF Patent in force
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)
PE Patent expired

Effective date: 20190323